Congress tightens hospice oversight with 5-year enrollment freeze and payment restructuring

What it does

This bill overhauls Medicare's hospice program by imposing a 5-year moratorium on new hospice enrollments (with exemptions for underserved areas), requiring enhanced oversight of newly enrolled programs, increasing survey frequency for newer hospices, and restructuring payment rates to separate routine home care into per-diem and per-visit components while adding higher payments for specific palliative treatments (chemotherapy, radiation, dialysis, transfusions). It also mandates physician independence in terminal illness certifications, requires advance notice of ownership changes, and funds new medical review and beneficiary notification systems.

Why we flagged it

The bill's core mechanism is a multi-layered regulatory tightening (moratorium, enhanced oversight, survey frequency increases, ownership disclosure) paired with payment restructuring that separates routine home care into per-diem and per-visit components and adds higher payments for specified palliative services. It is not primarily a deregulation or a simple payment cut; it is a comprehensive rebalancing of hospice program access, oversight, and compensation.

What the text implies

• The 5-year enrollment moratorium, even with exemptions, may create regional hospice shortages in areas that do not meet the 'insufficient access' threshold, potentially delaying end-of-life care access for some beneficiaries.
• Restructuring routine home care into per-diem and per-visit components (effective 2030) introduces administrative complexity and may incentivize higher visit counts if per-visit rates are set above cost, creating potential for overutilization.
• The 400% payment increase for specified palliative services (chemotherapy, radiation, dialysis, transfusions) through 2032 may attract for-profit hospices to focus on higher-acuity patients, potentially reducing services to lower-acuity populations.
• Mandatory physician independence in terminal illness certifications and plan-of-care reviews for palliative services may reduce hospice autonomy and increase administrative delays, particularly in rural areas with limited specialist availability.
• The bill funds $20M for medical review and $10M for beneficiary notifications in FY2027, but does not specify ongoing funding; if appropriations lapse, oversight and transparency initiatives may be curtailed.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Beneficiaries gain stronger protections through physician independence requirements, advance ownership-change notice, and detailed election explanations, plus expanded access to palliative treatments (chemotherapy, radiation, dialysis) at higher payment rates. However, the 5-year enrollment moratorium may reduce hospice availability in some areas despite exemptions, and the bill's complexity and new compliance burdens may indirectly increase costs or reduce service quality if hospices pass compl

Who stands to gain

• Hospice programs providing specified palliative services (chemotherapy, radiation, dialysis, transfu
• Oncologists and nephrologists supervising palliative care — required involvement in plan-of-care rev
• Medical review contractors — $20M in new funding for prepayment and postpayment reviews
• Beneficiary notification and compliance service providers — $10M in funding for election notices and

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Secretary of Health and Human Services, Medicare Administrative Contractors, Recovery Audit Contractors, Supplemental Medical Review Contractors, Uniform Program Integrity Contractors, Hospice programs, Oncologists, Nephrologists, Physician assistants, Nurse practitioners, Federal Hospital Insurance Trust Fund — and 1 more

Where it stands

7 cosponsors: 6 Democrats, 1 Republicans.

• Mar 17, 2026 — Introduced · Congress.gov: “Introduced in House”
• Mar 17, 2026 — Referred to House Committee on Energy and Commerce and House Committee on Ways and Means · Congress.gov: “Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

5 lobbying clients named this bill on 5 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $2,090,000 in lobbying spend. A filing names 10 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 78% of bills with at least one filing.

Linda Sánchez, the sponsor, reported $1,249,899 in PAC receipts in the 2026 cycle. $7,500 of that came from 1 PAC tied to these lobbying clients.

• Abbott Laboratories — $1,150,000 on 1 filing
• National Alliance for Care at Home (formerly Natl Assn for Home Care & Hospice) — $610,000 on 1 filing
• Vitas Healthcare Corporation — $230,000 on 1 filing
• The National Alliance for Care at Home — $50,000 on 1 filing
• Vitas Healthcare — $50,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.